Drug Profile
Research programme: modified tetracyclines - Tetragenex
Alternative Names: INN 01137; INN 01147Latest Information Update: 27 Apr 2010
Price :
$50
*
At a glance
- Originator Tetragenex Pharmaceuticals
- Class Tetracyclines
- Mechanism of Action Matrix metalloproteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Malignant melanoma; Prostate cancer
Most Recent Events
- 31 Dec 2008 Preclinical trials in Bacterial infections in USA (unspecified route)
- 31 Dec 2008 Preclinical trials in Malignant melanoma in USA (unspecified route)
- 31 Dec 2008 Preclinical trials in Prostate cancer in USA (unspecified route)